Nubeqa® approved by the US Food and Drug Administration
FDA approves Nubeqa (darolutamide) as a new treatment for men…
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
List view / Grid view
FDA approves Nubeqa (darolutamide) as a new treatment for men…
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.